Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
2017 · Journal of Gastroenterology · 23 citations
https://doi.org/10.1007/s00535-017-1348-8